A/Prof Charles is a cancer pharmacologist with 15 years of cancer and immunology drug development, and has participated in national and international clinical trials. She is a current Bellberry Human Research Ethics Committee member specialising the scientific expert review of clinical pharmacology, toxicology and clinical trial design of cancer and immunology new investigational products.

A/Prof Chou is a surgical pathologist at the Royal North Shore Hospital. She has over 14 years of subspecialty experience in gastrointestinal (GIT) pathology, lung pathology, endocrine pathology, and molecular pathology. She is actively involved in teaching at the University of Sydney and translational cancer research at the Kolling Institute. She is a Fellow of the Royal College of Pathologists of Australasia and completed her Bachelor of Medicine/Surgery and PhD at the University of NSW.

Dr Colvin is a gynaecological cancer researcher based at the Kolling Institute, University of Sydney. Her research aims to characterise the role of non-coding RNAs in the ovarian tumour microenvironment, particularly their role in the spread of ovarian cancer. She is also investigating the potential of using “liquid biopsy”, rather than tissue biopsy, to monitor treatment response in patients with ovarian and endometrial cancers. Dr Colvin is a keen advocate for the health and medical research sector and is the immediate Past-President of the Australian Society for Medical Research.

Dr Kodsi is an Australian trained adult medicine physician, who has qualifications in palliative medicine and pain medicine. He is also supervisor of training of trainees in pain medicine, and regularly is involved in the teaching of undergraduate and postgraduate medical professionals. Dr Kodsi is a board-certified Specialist in Pain Medicine and in Palliative Medicine and has fellowships with the Faculty of Pain Medicine ANZCA (FFPMANZCA), the Royal Australasian College of Physicians (FRACP) and The Chapter of Palliative Medicine (FAChPM).

Dr Lim is a senior lecturer and postdoctoral fellow within the Precision Cancer Therapy group at Macquarie University. Her research focuses on investigating the genomic, transcriptomic and proteomic expression profiles of melanoma patients treated with targeted therapies and immunotherapies, and examining the mechanisms underlying response to these therapies. She also co-supervises HDR students and convene and teaches into the Bachelor of Clinical Science and Bachelor of Medical Science courses at Macquarie University.